InterCure Ltd. Form 6-K Summary
Reporting period: Form 6-K filed April 20, 2023, covering the month of April 2023. InterCure Ltd. is an Israeli foreign private issuer filing annual reports on Form 20-F.
Business Context
The filing identifies InterCure Ltd., headquartered in Herzliya, Israel. The submission includes Exhibit 99.1, described as a press release dated April 20, 2023, but the press release text is not included in the provided filing content.
Financial and Operating Metrics
The filing text provided does not contain clear values for revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Changes, Outlook, and Risks
The provided filing text does not describe material changes versus a prior comparable period, guidance, outlook, management commentary, risks, contingencies, or unusual items. These matters may be addressed in the omitted Exhibit 99.1 press release.
Investor Verification Items
- Obtain and review Exhibit 99.1, the April 20, 2023 press release.
- Verify any financial results, operational developments, guidance, or transaction details described in the exhibit.
- Review the company’s relevant Form 20-F and subsequent filings for complete financial and risk disclosures.